Skip to main navigation
Home

Search form

  • About Us

    • Profile & Mission

    • Our Strategy

    • Leadership Team

    • Company Histroy

  • Our Products

  • Cumberland Emerging Technologies

  • Investor Relations

    Investor Relations

    • Investor Relations
    • Corporate Update
    • Corporate Governance
      • Committees
      • Contact the Board
    • Stock Information
      • Historic Stock Lookup
      • Ownership Profile
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
      • Key Ratios
    • Events & Presentations
    • Investor FAQs
    • Press Releases
    • Contact IR
    3 Mo. 6 Mo. 1 Yr.

    Shareholder Tools

    Search Investor Relations

  • News

  • Blog

  • Contact Us

    Corporate Headquarters

    Cumberland Pharmaceuticals Inc.
    2525 West End Avenue, Suite 950
    Nashville, Tennessee 37203

    Phone: (615) 255-0068
    Toll Free: (877) 484-2700
    Fax: (615) 255-0094

    info@cumberlandpharma.com

    *For directions to us, please see Location

    Employment Opportunities

    employment@cumberlandpharma.com

    Investor Relations

    investors@cumberlandpharma.com

    Business Development

    development@cumberlandpharma.com

    Wholesaler Customer Service

    Phone: (877) 274-7200
    Fax: (614) 652-9127

    Medical Information

    This website is not for medical emergencies. If you are a patient, caregiver or healthcare professional and need product related information, please visit our Products page, which will link you to product-specific websites.

    Adverse Event Reporting

    Toll Free Phone: (866) 767-5077
    (For healthcare professionals only)

     

     

Investor Relations

  • Investor Relations
  • Corporate Update
  • Corporate Governance
    • Committees
    • Contact the Board
  • Stock Information
    • Historic Stock Lookup
    • Ownership Profile
  • Financial Information
    • SEC Filings
    • Annual Reports
    • Quarterly Results
    • Key Ratios
  • Events & Presentations
  • Investor FAQs
  • Press Releases
  • Contact IR
3 Mo. 6 Mo. 1 Yr.

Shareholder Tools

Search Investor Relations

 

News

In the News

Cumberland Pharmaceuticals Celebrates New Corporate Headquarters 717.1 KB
May 01, 2023
Tennessean – Lessons from COVID-19 Can Help US Fight Opioids 90.8 KB
Feb 15, 2021
Nashville Medical News - Which Leaders Keep Music City 92 Billion Healthcare Industry Humming 5.3 MB
Jan 29, 2021
LaunchTN – How CET is Bridging Innovative Healthcare Research and Entrepreneurship 163.1 KB
Jan 27, 2021
Nashville Medical News – Introducing RediTrex, A New Methotrexate Delivery System 79.3 KB
Dec 17, 2020
Nashville Medical News – Addressing Opioid Usage in the Hospital Setting 111.8 KB
Nov 19, 2020
Infectious Disease Special Edition (IDSE) – Vibativ Sustained Activity Confirmed in Two Surveillance Studies 167.8 KB
Nov 06, 2020
Pharmaceutical Industry’s Investment in Research, Development Paying Off 313.2 KB
Sep 18, 2020
Orthopedics This Week - The Effort to Reduce Opioid Use Gets A Boost From New Drugs 206 KB
Sep 14, 2020
COVID-19 Bacterial Pneumonia Virtual Expert Panel 285.7 KB
May 11, 2020

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Current page 2
Displaying 11 - 20 of 20
Cumberland Pharmaceuticals Inc. 1600 West End Avenue, Suite 1300, Nashville, Tennessee 37203
Site MapPrivacy PolicyTerms & Conditions